Toge her, We are

Helping healthcare providers further their mission through optimal financial performance

Operational Highlights

Continued operational and financial progress despite ongoing COVID-19 backdrop

New Sales* more than 30% ahead of strong comparable period in the prior year

Strong growth in Trisus® metrics

  • • More than 500 hospitals now using the Trisus platform

  • • Trisus solutions accounted for c. 16% of New Sales (H1 2020: 10%)

  • • Over 90m anonymised aggregated patient encounters included within data on the platform, an increase of 30% in the last 3 months

Remaining core solutions, Chargemaster Toolkit and Pharmacy ChargeLink, on track to be migrated to the Trisus platform within the next twelve months

Strong customer retention rates above 90% with dollar value of renewals returned to c.100%

*New Sales refers to the total value of contracts signed in the period with new customers or the sale of new products to existing customers.

Craneware plc

Interim Report 2021

Financial Highlights:

Revenue increased 6% to $38m (H1 2020: $35.9m)

$38m

Revenue

$13.3m

Adjusted EBITDA1 increased 5% to $13.3m (H1 2020: $12.7m)

Adjusted EBITDA1

$9.9m

Profit before tax increased 3% to $9.9m (H1 2020: $9.6m)

Profit

32.5¢

Adjusted basic EPS2 increased 5% to 32.5 cents per share (H1 2020: 31.1 cents per share)

Adjusted EPS2

Cash position of $50.7m (H1 2020: $45m)

$50.7m

Cash

Interim dividend increased 4% to 12p per share (H1 2020: 11.5p per share)

12.5p

Interim Dividend

Further investment in R&D and innovation of $11.6m (H1 2020: $10.3m), of which $4.5m capitalised (H1 2020: $4.0m), to take advantage of the growing market

$11.6m

Investment in R&D

Outlook:

Strong sales pipeline for the current financial year and beyond

As at end of December 2020, total visible revenues of $206.4m for the three-year period to June 2023 (H1 2020 same three-year period: $189.6m)

The Board is cognisant of the challenges presented by the macro environment but remains confident in the continued positive performance of the business

The Board's expectations for the full year ending 30 June 2021 remain unchanged

  • 1 Adjusted EBITDA refers to earnings before interest, tax, depreciation, amortisation, share based payments and acquisition and share transaction related costs

  • 2 Adjusted Earnings per share (EPS) calculations allow for the tax adjusted acquisition costs and share related transactions together with amortisation on acquired intangible assets

Craneware plc Interim Report 2021

Craneware Solutions

Chargemaster Tooolkit®

Automated SaaS chargemaster management solutions for capturing optimal legitimate reimbursement for providers, while mitigating compliance risk. Chargemaster Toolkit is customisable for any organisation, from small community providers to large healthcare networks, and addresses the challenges that enterprise chargemaster data presents to hospitals by enabling all related chargemaster data to be viewed in one place.

Charge Capture & Pricing

Improves charge capture, pricing and cost management, while simplifying the process for ensuring drug coding and billing units are complete and compliant, and establishing and maintaining a connection between a provider's pharmaceutical purchases and billing.

Pharmacy ChargeLink®

Craneware plc Interim Report 2021

Trisus® Supply

Utilizes foundational data from the item master, OR file, and chargemaster to identify data gaps between the systems, ensuring every reimbursable supply, implant, and device is billed.

SaaS solution that simplifies the price modelling process, creating a repeatable, well-documented method to establish transparent, defensible and competitive pricing.

Pricing Analyzer™

Physician Revenue Toolkit®

SaaS solutions for managing physician group KPIs, charges, codes, RVUs, fee schedules, and related information

Reference Plus™

SaaS solution for providers with less than $44 million in operating expenses to perform chargemaster analysis, and efficiently optimise revenue, charge compliance and coding integrity.

Web-based and mobile-friendly tool for reducing risk by providing access to reference and regulatory resources.

Online Reference Toolkit®

Interface Scripting Module

Software that automatically uploads chargemaster changes to the patient billing system for accurate billing.

Patient Engagement

Web-based, mobile-friendly supplies lookup tool available in Supplies ChargeLink or stand alone. Trisus Supplies Assistant enables providers to access Craneware's proprietary supply master catalog and quickly and correctly code expensive implants and devices.

Trisus Supplies Assistant

Craneware Value Cycle Solutions span five product families - Patient Engagement, Charge Ca In addition, hospitals of all sizes and types rely on Craneware's Customer Success Management

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Craneware plc published this content on 22 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 March 2021 10:16:06 UTC.